Close Menu

NEW YORK (GenomeWeb) – RainDance Technologies today announced several distribution agreements covering Europe and the Middle East. 

The deals are with BioTech-Europe, Diatech Pharmacogenetics, Labgene Scientific, and Neo-Science & Group. They will distribute RainDance products in Central and Eastern Europe, Italy, Switzerland, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.